The Japanese heart valve device market is large and expanding, with growth being driven primarily by the rapid adoption of THV devices and an aging population in this country. Additionally, as innovative devices and device types emerge in the coming years, new patient populations will be treated, leading to continued growth in this market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Japan across a 10-year period.


The TAVR device segment represents the largest growth opportunity in the Japanese heart valve device market.

What types of patients will be eligible for TAVR? What will be the market impact of the approval of expanded indications for TAVR?

What are some strategies that surgical heart valve manufacturers have used to mitigate the impact of THV device adoption?

Which new TAVR devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?

How will MHLW reimbursement affect TAVR adoption?

What other aspects of the Japanese regulatory environment will impact the uptake of TAVR?

Abbott Laboratories' MitraClip approval has introduced TMVR to the Japanese market for the first time.

How has the market reacted to the launch of this new class of device?

What impact will TMVR devices have on the surgical annuloplasty repair market?

Will new TMVR devices be able to compete with MitraClip when they enter the market?

There are a few large entrenched competitors in the Japanese heart valve device market.

What hurdles exist for new competitors trying to enter the Japanese heart valve device market, and what strategies can they use to overcome these barriers?

How will new market entrants compete with entrenched competitors?

How do physician attitudes affect device adoption and brand preference in Japan?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Heart Valve Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Emerging Technologies
        • Market Appeal
        • Mergers, Acquisitions, and Partnerships
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Distribution and Sales Network
        • Product Portfolio Management
      • Market Developments
    • Heart Valve Replacement Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Surgical Heart Valve Replacement Devices
        • Transcatheter Aortic Valve Replacement Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Emerging Technologies
        • Product Improvements and Innovations
        • Distribution and Sales Network
    • Heart Valve Repair Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Transcatheter Heart Valve Repair Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Emerging Technologies
        • Mergers, Acquisitions, and Partnerships
        • Product Improvements and Innovations
    • Heart Valve Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Drew Wallace

Drew C. Wallace is an analyst on the Cardiovascular Medtech Insights team, specializing in heart valve device markets. Drew holds a Master's degree in Developmental Biology from the University of Western Ontario.


Related Reports

Heart Valve Devices | Medtech 360 | Market Insights | United States

The US heart valve device market is the largest in the world and it continues to grow rapidly, due largely to the swift adoption of THV d...

View Details

Heart Valve Devices | Medtech 360 | Market Insights | Europe

The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflec...

View Details

Heart Valve Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devic...

View Details

Heart Valve Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American heart valve device market will experience robust growth, largely driven by an expanding patient pool, improving access to treatment, and rising adoption...

View Details